Predictive biomarkers of response to immune checkpoint inhibitors in melanoma

被引:22
作者
Nebhan, Caroline A. [1 ,2 ]
Johnson, Douglas B. [1 ,2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
关键词
Melanoma; immunotherapy; PD-1; biomarkers; CTLA-4; METASTATIC MELANOMA; CLINICAL-RESPONSE; CTLA-4; BLOCKADE; PD-1; T-CELLS; IPILIMUMAB; NIVOLUMAB; ANTI-PD-1; COMBINATION; LANDSCAPE;
D O I
10.1080/14737140.2020.1724539
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Advanced melanoma has recently been transformed by the advent of immune checkpoint inhibitors. These agents have altered the prognosis of this disease from a median survival of Areas covered: In this review, we discuss the clinical and investigational utility of predictive biomarkers of immune checkpoint inhibitor treatment in melanoma. Topics include tumor-intrinsic biomarkers, tumor microenvironment biomarkers, and host characteristic biomarkers. We also discuss biomarkers of immune-related adverse events and how biomarkers may be used to personalize the selection of immune checkpoint inhibition in patients. Expert opinion: The decisions confronting oncologists when choosing treatment are increasing in complexity. Biomarkers may aid in these treatment decisions and are growing in importance.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 72 条
[1]  
[Anonymous], SEER cancer statistics review, 1975-2017
[2]   High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].
Atkins, MB ;
Lotze, MT ;
Dutcher, JP ;
Fisher, RI ;
Weiss, G ;
Margolin, K ;
Abrams, J ;
Sznol, M ;
Parkinson, D ;
Hawkins, M ;
Paradise, C ;
Kunkel, L ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116
[3]   Combination of Alphavirus Replicon Particle-Based Vaccination with Immunomodulatory Antibodies: Therapeutic Activity in the B16 Melanoma Mouse Model and Immune Correlates [J].
Avogadri, Francesca ;
Zappasodi, Roberta ;
Yang, Arvin ;
Budhu, Sadna ;
Malandro, Nicole ;
Hirschhorn-Cymerman, Daniel ;
Tiwari, Shakuntala ;
Maughan, Maureen F. ;
Olmsted, Robert ;
Wolchok, Jedd D. ;
Merghoub, Taha .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (05) :448-458
[4]   IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade [J].
Ayers, Mark ;
Lunceford, Jared ;
Nebozhyn, Michael ;
Murphy, Erin ;
Loboda, Andrey ;
Kaufman, David R. ;
Albright, Andrew ;
Cheng, Jonathan D. ;
Kang, S. Peter ;
Shankaran, Veena ;
Piha-Paul, Sarina A. ;
Yearley, Jennifer ;
Seiwert, Tanguy Y. ;
Ribas, Antoni ;
McClanahan, Terrill K. .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (08) :2930-2940
[5]   Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination [J].
Boutros, Celine ;
Tarhini, Ahmad ;
Routier, Emilie ;
Lambotte, Olivier ;
Ladurie, Francois Leroy ;
Carbonnel, Franck ;
Izzeddine, Hassane ;
Marabelle, Aurelien ;
Champiat, Stephane ;
Berdelou, Armandine ;
Lanoy, Emilie ;
Texier, Matthieu ;
Libenciuc, Cristina ;
Eggermont, Alexander M. M. ;
Soria, Jean-Charles ;
Mateus, Christine ;
Robert, Caroline .
NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (08) :473-486
[6]   MYC regulates the antitumor immune response through CD47 and PD-L1 [J].
Casey, Stephanie C. ;
Tong, Ling ;
Li, Yulin ;
Do, Rachel ;
Walz, Susanne ;
Fitzgerald, Kelly N. ;
Gouw, Arvin M. ;
Baylot, Virginie ;
Guetgemann, Ines ;
Eilers, Martin ;
Felsher, Dean W. .
SCIENCE, 2016, 352 (6282) :227-231
[7]   Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden [J].
Chalmers, Zachary R. ;
Connelly, Caitlin F. ;
Fabrizio, David ;
Gay, Laurie ;
Ali, Siraj M. ;
Ennis, Riley ;
Schrock, Alexa ;
Campbell, Brittany ;
Shlien, Adam ;
Chmielecki, Juliann ;
Huang, Franklin ;
He, Yuting ;
Sun, James ;
Tabori, Uri ;
Kennedy, Mark ;
Lieber, Daniel S. ;
Roels, Steven ;
White, Jared ;
Otto, Geoffrey A. ;
Ross, Jeffrey S. ;
Garraway, Levi ;
Miller, Vincent A. ;
Stephens, Phillip J. ;
Frampton, Garrett M. .
GENOME MEDICINE, 2017, 9
[8]   Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade [J].
Chen, Pei-Ling ;
Roh, Whijae ;
Reuben, Alexandre ;
Cooper, Zachary A. ;
Spencer, Christine N. ;
Prieto, Peter A. ;
Miller, John P. ;
Bassett, Roland L. ;
Gopalakrishnan, Vancheswaran ;
Wani, Khalida ;
De Macedo, Mariana Petaccia ;
Austin-Breneman, Jacob L. ;
Jiang, Hong ;
Chang, Qing ;
Reddy, Sangeetha M. ;
Chen, Wei-Shen ;
Tetzlaff, Michael T. ;
Broaddus, Russell J. ;
Davies, Michael A. ;
Gershenwald, Jeffrey E. ;
Haydu, Lauren ;
Lazar, Alexander J. ;
Patel, Sapna P. ;
Hwu, Patrick ;
Hwu, Wen-Jen ;
Diab, Adi ;
Glitza, Isabella C. ;
Woodman, Scott E. ;
Vence, Luis M. ;
Wistuba, Ignacio I. ;
Amaria, Rodabe N. ;
Kwong, Lawrence N. ;
Prieto, Victor ;
Davis, R. Eric ;
Ma, Wencai ;
Overwijk, Willem W. ;
Sharpe, Arlene H. ;
Hu, Jianhua ;
Futreal, P. Andrew ;
Blando, Jorge ;
Sharma, Padmanee ;
Allison, James P. ;
Chin, Lynda ;
Wargo, Jennifer A. .
CANCER DISCOVERY, 2016, 6 (08) :827-837
[9]   Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy [J].
Chowell, Diego ;
Morris, Luc G. T. ;
Grigg, Claud M. ;
Weber, Jeffrey K. ;
Samstein, Robert M. ;
Makarov, Vladimir ;
Kuo, Fengshen ;
Kendall, Sviatoslav M. ;
Requena, David ;
Riaz, Nadeem ;
Greenbaum, Benjamin ;
Carroll, James ;
Garon, Edward ;
Hyman, David M. ;
Zehir, Ahmet ;
Solit, David ;
Berger, Michael ;
Zhou, Ruhong ;
Rizvi, Naiyer A. ;
Chan, Timothy A. .
SCIENCE, 2018, 359 (6375) :582-+
[10]   Cutaneous Melanoma Version 2.2019 [J].
Coit, Daniel G. ;
Thompson, John A. ;
Albertini, Mark R. ;
Barker, Christopher ;
Carson, William E., III ;
Contreras, Carlo ;
Daniels, Gregory A. ;
DiMaio, Dominick ;
Fields, Ryan C. ;
Fleming, Martin D. ;
Freeman, Morganna ;
Galan, Anjela ;
Gastman, Brian ;
Guild, Valerie ;
Johnson, Douglas ;
Joseph, Richard W. ;
Lange, Julie R. ;
Nath, Sameer ;
Olszanski, Anthony J. ;
Ott, Patrick ;
Gupta, Aparna Priyanath ;
Ross, Merrick, I ;
Salama, April K. ;
Skitzki, Joseph ;
Sosman, Jeffrey ;
Swetter, Susan M. ;
Tanabe, Kenneth K. ;
Wuthrick, Evan ;
McMillian, Nicole R. ;
Engh, Anita M. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (04) :367-402